Clin Mol Hepatol > Accepted Articles
Ursolic acid: A promising therapeutic agent for MASLD via inhibition of SPP1-induced Th17 cell differentiation
So Jung Kim, Jeongeun Hyun
Department of Nanobiomedical Science and BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan 31116, Republic of Korea
Correspondence :  Jeongeun Hyun ,
Email: j.hyun@dankook.ac.kr
Received: May 31, 2024   Accepted: June 6, 2024
KeyWords: Non-alcoholic fatty liver disease; Ursolic acid; Secreted phosphoprotein 1; Helper T 17
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 313 View
  • 29 Download
ORCID iDs

Jeongeun Hyun
https://orcid.org/0000-0003-1144-2552

Related articles

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 308
TOTAL : 1931411
Close layer